1304 related articles for article (PubMed ID: 17519647)
1. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
3. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
5. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
6. Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine.
Chasson GS; Buhlmann U; Tolin DF; Rao SR; Reese HE; Rowley T; Welsh KS; Wilhelm S
Behav Res Ther; 2010 Jul; 48(7):675-9. PubMed ID: 20362975
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
[TBL] [Abstract][Full Text] [Related]
8. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
9. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
11. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
[TBL] [Abstract][Full Text] [Related]
13. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
Franklin ME; Abramowitz JS; Kozak MJ; Levitt JT; Foa EB
J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
[TBL] [Abstract][Full Text] [Related]
16. An integrated approach to treatment of obsessive compulsive disorder.
Greist JH
J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
[TBL] [Abstract][Full Text] [Related]
17. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
Xia J; Du Y; Han J; Liu G; Wang X
Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
[TBL] [Abstract][Full Text] [Related]
18. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
[TBL] [Abstract][Full Text] [Related]
19. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.
Fisher PL; Wells A
Behav Res Ther; 2005 Dec; 43(12):1543-58. PubMed ID: 16239151
[TBL] [Abstract][Full Text] [Related]
20. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
